Left Atrial Appendage Closure Device

Left Atrial Appendage Closure Devices Market Executive Summary, Segmentation, Review, Trends, Opportunities, Growth, Demand and Forecast to 2031

The global left atrial appendage closure (LAAC) devices market is expected to witness substantial growth and is projected to expand at a CAGR of nearly 15% over the next five years. The increasing ...

Morningstar

CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and ...

MARLBOROUGH, Mass. and NEW ORLEANS, March 28, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that the CHAMPION-AF global clinical trial met all primary and secondary ...

News Medical

Left atrial appendage closure matches anticoagulants in AFib patients

For patients with non-valvular atrial fibrillation (AFib) who had no contraindications to taking oral anticoagulants, the use of a device to close off the left atrial appendage in the heart—a small ...

Healio

Left atrial appendage closure safe, effective first-line option for AF ablation patients

Please provide your email address to receive an email when new articles are posted on . OPTION is a head-to-head trial of left atrial appendage closure with Watchman FLX vs. anticoagulation after ...

11h

Vascular Closure Devices Market Set to Surge to USD 4.08 Billion by 2035, Growing at 7.85% CAGR | Research by SNS Insider

U.S. market projected to surpass USD 1.00 billion by 2035, while Europe advances through high PCI volumes and stricter MDR-driven vascular device standards.Austin, United States, May 22, 2026 (GLOBE ...

TCTMD

Show inaccessible results